Biller J, Love B B, Marsh E E, Jones M P, Knepper L E, Jiang D, Adams H P, Gordon D L
Department of Neurology, University of Iowa College of Medicine, Iowa City 52242.
Stroke. 1990 Jul;21(7):1008-12. doi: 10.1161/01.str.21.7.1008.
Recent clinical studies emphasize the importance of early (less than 12 hours after onset) treatment of patients with acute ischemic stroke. Therapies have been proposed as being effective because of early clinical improvement. The frequency and degree of spontaneous improvement in such patients, however, is unknown. We prospectively evaluated the course of 29 patients (19 men, 10 women) aged 33-82 years who were seen less than or equal to 12 hours after the onset of acute ischemic stroke. Seventeen patients were first evaluated less than or equal to 6 hours and the remaining patients at 6-12 hours after onset. All patients were examined using a modified National Institutes of Health Stroke Scale at baseline, 1, 2, 3, and 6 hours. No specific treatment for acute ischemic stroke was given during this time. Improvement (defined as a decrease of greater than or equal to 2 points from baseline score) was noted at 1 hour in seven patients (24%). By 6 hours 15 patients (52%) had improved, 12 (41%) were unchanged, and two (7%) were worse. Our results suggest that spontaneous, often dramatic improvement occurs in patients with acute ischemic stroke and should be taken into consideration in the design of any trial of acute treatment.
近期的临床研究强调了对急性缺血性中风患者进行早期(发病后12小时内)治疗的重要性。由于早期临床症状改善,一些治疗方法被认为是有效的。然而,这类患者自发改善的频率和程度尚不清楚。我们前瞻性地评估了29例年龄在33 - 82岁之间的患者(19名男性,10名女性),他们在急性缺血性中风发病后12小时内或更早被就诊。17例患者在发病后6小时内或更早接受首次评估,其余患者在发病后6 - 12小时接受评估。所有患者在基线、发病后1小时、2小时、3小时和6小时使用改良的美国国立卫生研究院卒中量表进行检查。在此期间未给予急性缺血性中风的特定治疗。7例患者(24%)在1小时时出现改善(定义为较基线评分下降大于或等于2分)。到6小时时,15例患者(52%)有所改善,12例(41%)无变化,2例(7%)病情恶化。我们的结果表明,急性缺血性中风患者会出现自发的、通常显著的改善,在任何急性治疗试验的设计中都应考虑到这一点。